Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer

Background: We hypothesized that non-small cell lung cancer (NSCLC) patients with a tumor positive for single nucleotide polymorphisms (SNPs) of the Excision Repair Cross Complementation Group 1 (ERCC-1) gene could be more genetically instable and consequently more responsive to a programmed cell de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Aiello, Marco Maria, Solinas, Cinzia, Santoni, Matteo, Battelli, Nicola, Restuccia, Nunzio, Latteri, Fiorenza, Paratore, Sabrina, Verderame, Francesco, Albanese, Giuseppina Valeria, Bruzzi, Paolo, Soto Parra, Hector Josè
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493643/
https://ncbi.nlm.nih.gov/pubmed/32983959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01167
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados